The FDA has recalled about 3,408 gallons of Brooklyn Roasting Company Pasteurized Cold Brew Concentrate after a potential Clostridium botulinum contamination risk. The recall covers 2.5-gallon bottles sold in New Jersey and New York from April 1 to June 20, 2026, with best-by dates from June 30 to September 30, 2026. Consumers should not consume affected products and should dispose of or return them; seek immediate medical care if you develop symptoms of botulism. Contact the FDA at 1-888-463-6332 for more information.
FDA Recalls 3,408 Gallons of Brooklyn Roasting Cold Brew Over Botulism Risk

The U.S. Food and Drug Administration (FDA) has announced a recall of approximately 3,408 gallons of Brooklyn Roasting Company Cold Brew due to a potential contamination with Clostridium botulinum, the bacterium that can produce botulinum toxin.
Recall Details
The recall applies to Brooklyn Roasting Company Pasteurized Cold Brew Concentrate that was distributed and sold in New Jersey and New York between April 1 and June 20, 2026. The affected product was packaged in 2.5-gallon bottles bearing best-by dates from June 30 through September 30, 2026.
Why It Was Recalled
According to the FDA, the product may have been exposed to room-temperature conditions during distribution, which can create circumstances that allow Clostridium botulinum to produce toxin even in pasteurized products. Botulinum toxin can cause the serious illness botulism.
What Consumers Should Do
- Do not taste or consume the product if it matches the description above.
- Dispose of the product safely or return it to the place of purchase for a possible refund.
- If you believe you have consumed the recalled cold brew and develop symptoms, seek medical attention immediately and inform health providers about the possible exposure.
Symptoms of Botulism
Botulism affects the nervous system. Symptoms can include:
- Bloating and constipation
- Muscle weakness and dizziness
- Double or blurred vision
- Difficulty speaking, swallowing, or breathing
FDA Classification and Contact
On July 21, the FDA classified this recall as Class II, indicating a remote probability of adverse health consequences; exposure may cause temporary or medically reversible health effects. For questions, consumers can call the FDA at 1-888-INFO-FDA (1-888-463-6332).
Source: FDA recall announcement (reported by EatingWell).
Help us improve.

























